Search NASA⌕ Search

SEARCH · Search NASA

Results for “collimation”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,441 records · Page 80

Induced Radioactivity Analysis for the NSRL Linac in China Using Monte Carlo Simulations and Gamma Spectroscopy - Paper 141

The Synchrotron Radiation Facility of the National Synchrotron Radiation Laboratory (NSRL) located in Hefei, China consists of a 200-MeV electron linear accelerator and an 800-MeV electronic storage ring. Constructed in 1989, the 200-MeV Electron linac is one of the earliest high-energy electron linear accelerators in China. The NSRL is a large-scale experiment device, having been operated more than twenty years, so it is hard to give a historical recount about the injection of NSRL Linac. Lower-energy electrons emitted from the accelerator electron gun are progressively accelerated to about 200 MeV in five acceleration tubes, and then are injected into the electron storage ring, reaching the final energy of 800 MeV. The linear accelerator is a traveling wave linear accelerator, consisting of pre-injection, four 6-m acceleration segment, some beam sensing elements, and focusing inserts. The electrons are accelerated in the acceleration tubes to 32 MeV, 74 MeV, 116 MeV, 158 MeV, respectively, and the electronic energy reaches 200 MeV at the end of the acceleration trip. A scraper is used for beam collimation and is located at the end of each acceleration tube, with a length that increases with the energy to provide sufficient collimation. The NSRL Linac was retired in 2012 due to a plan to upgrade the facility. The decommissioning produced many real challenges related to the methods to handle the large size of the device and the time required to store structural materials until the radioactivity is reduced in the waste repository. These problems should be solved as soon as possible in order for the upgrade to proceed smoothly. At present, no prior decommissioning experience existed in China on such a high-energy electron linear accelerator. Therefore, the decommission project provided an opportunity to study and evaluate the challenges, in particular, involving the induced radioactivity for the purposes of radiation protection. For a well-shielded accelerator facility, the induced radioactivity is an important source of radiation for people who perform the decommissioning. In addition, information on the level of induced radioactivity is needed for disposing of the retired accelerator materials. Therefore it is significant to predict such radioactivity level accurately. However, the induced radioactivity study for such type high-energy electron linear accelerator is very seldom. Particle accelerators that operate at energy greater than 10 MeV will produce induced radioactivity due to well-known photonuclear interactions. However, the assessment of such as induced radioactivity of large-scale installations is a time-consuming process. Experimental methods are time-consuming and require special radiation safety measures to protection the investigators. On the other hand, empirical formula cannot yield sufficiently accurate results. Therefore, Monte Carlo simulation method is the primary means to study such problems. In the decommissioning process of the NSRL Linac, the induced radioactivity assessment will be based on Monte Carlo simulation method as the main auxiliary means to expand a series of studies. (authors)

43 PARTICLE ACCELERATORS↗

DESIGN AND VALIDATION OF A GAMMA-RAY SCANNING SYSTEM FOR MEASURING IRRADIATED NUCLEAR FUEL (ABSTRACT)

A prototype gamma-ray scanning system was designed to perform post-irradiation measurements of nuclear fuel at Idaho National Laboratory (INL). The system is composed of a coaxial high-purity germanium (HPGe) detector, a collimator, and mechanical positioning stages that translate the fuel sample across the front of the collimator. This paper documents the design process, modeling and the laboratory characterization performed to validate the system. The modeling of the system was done using the Monte Carlo N-Particle code with vendor-supplied design specifications, dimensional measurements, and x-ray radiographs of the HPGe detector. The characterization included measurements of calibrated radiation sources in different geometries, and calculations for absolute efficiency and dead time. Benchmark measurements were performed by scanning an irradiated fuel rodlet containing ten pellets of 4.9% enriched UO2 in zirconium alloy. These results were compared to simulated spectra to further help characterize the detector model. One goal of the system is to determine the number of fissions per gram of UO2 in the fuel; comparison of the results from this prototype system's assay of the irradiated fuel rodlet are in agreement with previously estimated results.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

Measurements of Irradiated Low Enriched Fuel with a Gamma-Ray Scanning System (ANIMMA 2023 Conference Presentation)

A gamma-ray scanning system was designed to perform post-irradiation measurements of nuclear fuel at Idaho National Laboratory (INL). The system is composed of a coaxial high-purity germanium (HPGe) detector, a collimator, and mechanical positioning stages that translate the fuel sample across the front of the collimator. A Monte Carlo N-Particle code simulation of the system and the fuel were created with vendor-supplied design specifications, dimensional measurements, and x-ray radiographs of the HPGe detector as well as all available fuel specifications. Benchmark measurements were performed by scanning an irradiated fuel rodlet containing eight pellets of 0.74% enriched UO2 in zirconium alloy. This fuel rodlet was part of the Environment Rodlet Transient Test Apparatus (SERTTA) testing campaign in the Transient Reactor Test Facility (TREAT). These results were compared to simulated spectra to help characterize the detector model and establish fidelity. One goal of the system is to determine the number of fissions per gram of UO2 in the fuel. This article documents the modeling, benchmarking measurements, and the calculated number of fissions per gram in the SERTTA-A rodlet which was previously irradiated at TREAT.

11 - NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Improvements to In-Canal Assay of High Specific Activity 60Co at the ATR

Improvements to the quality of measurements in the assaying of High Specific Activity (HSA) cobalt 60 produced at the Advanced Test Reactor at the Idaho National Laboratory are presented. Such assays are conducted regularly between cycles at the ATR, and due to the radiological safety concerns, they are performed within the ATR canal. A standard ion chamber detector was placed in a collimated assay tube within the canal. Another tube, parallel to the detector, was used to position various cobalt 60 standards and targets. The collimated port between these tubes allows for the targets to be pulled across via a winch system. Previous measurements were performed at discrete 1.5-inch steps using a hand-cranked winch system. Charge was collected and integrated for 10 seconds at each discrete step during a scan. Two substantial improvements to the assay include an electronically controlled, motor-driven winch system and a software controlled continuous charge collection. Combined, these changes improved the quality of measurements as well as streamline the assay process. Further examination of these charge profiles indicated a reasonable amount of photon scattering, or shine, before a line-of-sight is established. This created inaccuracies in the reported activity of the cobalt targets. A series of MCNP-6.3 calculations were performed in an effort to quantify and correct for this shine effect. The results of the calculations and how they were employed to a create shine correction factor for the in-canal cobalt assay at the ATR are presented. The overall bias showed an overestimation of the HSA cobalt 60 activity by around 7-8%.

07 - ISOTOPES AND RADIATION SOURCES↗

Astrophysical jets with conical wire arrays : radiative cooling, rotation & deflection.

Highly collimated outflows or jets are produced by a number of astrophysical objects including protostars. The morphology and collimation of these jets is thought to be strongly influenced by the effects of radiative cooling, angular momentum and the interstellar medium surrounding the jet. Astrophysically relevant experiments are performed with conical wire array z-pinches investigating each of these effects. It is possible in each case to enter the appropriate parameter regime, leading the way towards future experiments where these different techniques can be more fully combined.

71 CLASSICAL AND QUANTUM MECHANICS, GENERAL PHYSIC↗

Microgamma Scan System for analyzing radial isotopic profiles of irradiated transmutation fuels

The U. S. Global Nuclear Energy Partnership / Advanced Fuel Cycle Initiative (GNEP/AFCI) is developing metallic transmutation alloys as a fuel form to transmute the long-lived transuranic actinide isotopes contained in spent nuclear fuel into shorter-lived fission products. The AFCI program has irradiated and examined eleven metallic alloy transmutation fuel specimens to evaluate the feasibility of actinide transmutation in advanced sodium-cooled fast reactors and thermal reactor implementation. Initial results of postirradiation examinations indicated the irradiation performance of the actinide-bearing compositions is similar to uranium-plutonium-zirconium ternary metallic alloy fuels (U-xPu-10Zr). Further studies to characterize radial burnup profile, constituent migration, and fuel cladding chemical interaction (FCCI) are in progress. A microgamma scan system is being developed to analyze the radial distribution of fission products, such as Cs-137, Cs-134, Ru-106, and Zr-95, in irradiated fuel cross-sections. The microgamma scan system consists of a set of indexed sample collimator blocks and a sample holder, which interfaces with the INL Analytical Laboratory Hot Cell (ALHC) Gamma Scan System high purity germanium detector, multichannel analyzer, and removable collimators. The microgamma scan results will be used to evaluate radial burnup profile, cesium migration to the sodium bond and constituent migration within the fuel. These data will further clarify the comparative irradiation performance of actinide-bearing metallic transmutation fuel forms and uranium-plutonium-zirconium alloys. Preliminary measurements of the microgamma scan system will be discussed. A simplified model of the microgamma scan system was developed in MCNP and used to investigate the system performance and to interpret data from the scoping studies. Recommendations for improving the MCGS analyses are discussed.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Compared vulnerabilities to small cardiac motions between different cameras used for myocardial perfusion imaging

This phantom-based study was aimed to determine whether cardiac CZT-cameras, which provide an enhanced spatial resolution and image contrast compared to Anger cameras, are similarly affected by small cardiac motions. Translations of a left ventricular (LV) insert at half-SPECT acquisitions through six possible orthogonal directions and with 5- or 10-mm amplitude were simulated on the Discovery NM-530c and DSPECT CZT-cameras and on an Anger Symbia T2 camera equipped with an astigmatic (IQ.SPECT) or conventional parallel-hole collimator (Conv.SPECT). SPECT images were initially reconstructed as currently recommended for clinical routine. The heterogeneity in recorded activity from the 17 LV segments gradually increased between baseline and motions simulated at 5- and 10-mm amplitudes with all cameras, although being higher for Anger- than CZT-cameras at each step and resulting in a higher mean number of artifactual abnormal segments (at 10-mm amplitude, Conv.SPECT: 3.7; IQ.SPECT: 1.8, Discovery: 0.7, DSPECT: 0). However, this vulnerability to motion was markedly (1) decreased for Conv.SPECT reconstructed without the recommended Resolution Recovery algorithm and (2) increased for DSPECT reconstructed without the recommended cardiac model. CZT-cameras and especially the DSPECT appear less vulnerable to small cardiac motions than Anger-cameras although these differences are strongly dependent on reconstruction parameters.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Non-cubic crystal symmetry of CaSiO{sub 3} perovskite up to 18 GPa and 1600K.

In situ synchrotron X-ray diffraction experiments have been conducted on CaSiO{sub 3} perovskite (CaPv) in a double-stage multianvil apparatus up to 18 GPa and 1600 K using a newly developed step-scan diffraction technique, which utilizes an energy-dispersive setup with a solid-state detector and collimator assemblies to collect angle-dispersive diffraction data over a wide range of photon energies. Superlattice reflections were resolved throughout the pressure (P) and temperature (T) range of the experiments, confirming that the crystal symmetry of CaPv is neither cubic nor tetragonal. A combination of analyses of the complete two-dimensional intensity datasets (photon energy from 20 to 160 keV and 2{theta} angle from 3.0{sup o} to 9.0{sup o}) and Rietveld refinements at selected wavelengths revealed that the most likely space group of CaPv in the experimental P-T range, and therefore in the Earth's transition zone, is either Pbnm or Cmcm. The difference between these two space groups was too small to resolve with our technique.

43 PARTICLE ACCELERATORS↗

Evaluation of Breast Sentinel Lymph Node Coverage by Standard Radiation Therapy Fields

Background: Biopsy of the breast sentinel lymph node (SLN) is now a standard staging procedure for early-stage invasive breast cancer. The anatomic location of the breast SLN and its relationship to standard radiation fields has not been described. Methods and Materials: A retrospective review of radiotherapy treatment planning data sets was performed in patients with breast cancer who had undergone SLN biopsy, and those with a surgical clip at the SLN biopsy site were identified. The location of the clip was evaluated relative to vertebral body level on an anterior-posterior digitally reconstructed radiograph, treated whole-breast tangential radiation fields, and standard axillary fields in 106 data sets meeting these criteria. Results: The breast SLN varied in vertebral body level position, ranging from T2 to T7 but most commonly opposite T4. The SLN clip was located below the base of the clavicle in 90%, and hence would be excluded from standard axillary radiotherapy fields where the inferior border is placed at this level. The clip was within the irradiated whole-breast tangent fields in 78%, beneath the superior-posterior corner multileaf collimators in 12%, and outside the tangent field borders in 10%. Conclusions: Standard axillary fields do not encompass the lymph nodes at highest risk of containing tumor in breast cancer patients. Elimination of the superior-posterior corner MLCs from the tangent field design would result in inclusion of the breast SLN in 90% of patients treated with standard whole-breast irradiation.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Helical Tomotherapy Quality Assurance

Helical tomotherapy uses a dynamic delivery in which the gantry, treatment couch, and multileaf collimator leaves are all in motion during treatment. This results in highly conformal radiotherapy, but the complexity of the delivery is partially hidden from the end-user because of the extensive integration and automation of the tomotherapy control systems. This presents a challenge to the medical physicist who is expected to be both a system user and an expert, capable of verifying relevant aspects of treatment delivery. A related issue is that a clinical tomotherapy planning system arrives at a customer's site already commissioned by the manufacturer, not by the clinical physicist. The clinical physicist and the manufacturer's representative verify the commissioning at the customer site before acceptance. Theoretically, treatment could begin immediately after acceptance. However, the clinical physicist is responsible for the safe and proper use of the machine. In addition, the therapists and radiation oncologists need to understand the important machine characteristics before treatment can proceed. Typically, treatment begins about 2 weeks after acceptance. This report presents an overview of the tomotherapy system. Helical tomotherapy has unique dosimetry characteristics, and some of those features are emphasized. The integrated treatment planning, delivery, and patient-plan quality assurance process is described. A quality assurance protocol is proposed, with an emphasis on what a clinical medical physicist could and should check. Additionally, aspects of a tomotherapy quality assurance program that could be checked automatically and remotely because of its inherent imaging system and integrated database are discussed.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Long-Term Outcomes of IMRT for Breast Cancer: A Single-Institution Cohort Analysis

Purpose: To evaluate long-term outcomes of adjuvant breast intensity-modulated radiation therapy (IMRT), with a comparison cohort receiving conventional radiation (cRT) during the same period. Methods and Materials: Retrospective review identified patients with Stages 0-III breast cancer who underwent irradiation after conservative surgery from January 1999 to December 2003. Computed tomography simulation was used to design standard tangential breast fields with enhanced dynamic wedges for cRT and both enhanced dynamic wedges and dynamic multileaf collimators for IMRT. Patients received 1.8-2-Gy fractions to 44-50.4 Gy to the whole breast, followed by an electron boost of 10-20 Gy. Results: A total of 245 breasts were treated in 240 patients: 121 with IMRT and 124 with cRT. Median breast dose was 50 Gy, and median total dose was 60 Gy in both groups. Patient characteristics were well balanced between groups. Median follow-ups were 6.3 years (range, 3.7-104 months) for patients treated with IMRT and 7.5 years (range, 4.9-112 months) for those treated with cRT. Treatment with IMRT decreased acute skin toxicity of Radiation Therapy Oncology Group Grade 2 or 3 compared with cRT (39% vs. 52%; p = 0.047). For patients with Stages I-III (n = 199), 7-year Kaplan-Meier freedom from ipsilateral breast tumor recurrence (IBTR) rates were 95% for IMRT and 90% for cRT (p = 0.36). For patients with Stage 0 (ductal carcinoma in situ, n = 46), 7-year freedom from IBTR rates were 92% for IMRT and 81% for cRT (p = 0.29). Comparing IMRT with cRT, there were no statistically significant differences in overall survival, disease-specific survival, or freedom from IBTR, contralateral breast tumor recurrence, distant metastasis, late toxicity, or second malignancies. Conclusions: Patients treated with breast IMRT had decreased acute skin toxicity, and long-term follow-up shows excellent local control similar to a contemporaneous cohort treated with cRT.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Dose Distribution Analysis of Axillary Lymph Nodes for Three-Dimensional Conformal Radiotherapy With a Field-in-Field Technique for Breast Cancer

Purpose: We previously reported that most of axillary regions could be irradiated by the modified tangential irradiation technique (MTIT). The purpose of this study was to determine whether the three-dimensional conformal radiotherapy (3D-CRT) with a field-in-field technique improves dosimetry for the breast and axillary nodes. Methods and Materials: Fifty patients with left-sided breast cancer were enrolled. With MTIT, we planned the radiation field to be wider in the cranial direction than the standard tangential fields to include the axillary regions. With 3D-CRT, a field-in-field technique was used to spare the heart and contralateral breast to the extent possible by applying the multileaf collimator manually. Dose-volume histograms were compared for the breast, axillary region, heart, lung, and other normal tissues. Results: There were no significant differences in the percent volume of the breast receiving >90% of the prescribed dose (V90) between MTIT and 3D-CRT. The mean V90 of the level I to III axillary regions were increased from 93.7%, 48.2%, and 41.3% with MTIT to 97.6%, 85.8%, and 82.8% with 3D-CRT. 3D-CRT significantly reduced the volume of the heart receiving >30 Gy (mean, 7.6 vs. 15.9 mL), the percent volume of the bilateral lung receiving >20 Gy (7.4% vs. 8.9%), and the volume of other normal tissues receiving >107% of the prescribed dose (0.1 vs. 2.9 mL). Conclusion: The use of 3D-CRT with a field-in-field technique improves axillary node coverage, while decreasing doses to the heart, lungs, and the other normal tissues, compared with MTIT.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Underestimation of Low-Dose Radiation in Treatment Planning of Intensity-Modulated Radiotherapy

Purpose: To investigate potential dose calculation errors in the low-dose regions and identify causes of such errors for intensity-modulated radiotherapy (IMRT). Methods and Materials: The IMRT treatment plans of 23 patients with lung cancer and mesothelioma were reviewed. Of these patients, 15 had severe pulmonary complications after radiotherapy. Two commercial treatment-planning systems (TPSs) and a Monte Carlo system were used to calculate and compare dose distributions and dose-volume parameters of the target volumes and critical structures. The effect of tissue heterogeneity, multileaf collimator (MLC) modeling, beam modeling, and other factors that could contribute to the differences in IMRT dose calculations were analyzed. Results: In the commercial TPS-generated IMRT plans, dose calculation errors primarily occurred in the low-dose regions of IMRT plans (<50% of the radiation dose prescribed for the tumor). Although errors in the dose-volume histograms of the normal lung were small (<5%) above 10 Gy, underestimation of dose <10 Gy was found to be up to 25% in patients with mesothelioma or large target volumes. These errors were found to be caused by inadequate modeling of MLC transmission and leaf scatter in commercial TPSs. The degree of low-dose errors depends on the target volumes and the degree of intensity modulation. Conclusions: Secondary radiation from MLCs contributes a significant portion of low dose in IMRT plans. Dose underestimation could occur in conventional IMRT dose calculations if such low-dose radiation is not properly accounted for.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Commissioning and Quality Assurance of RapidArc Radiotherapy Delivery System

Purpose: The Varian RapidArc is a system for intensity-modulated radiotherapy (IMRT) treatment planning and delivery. RapidArc incorporates capabilities such as variable dose-rate, variable gantry speed, and accurate and fast dynamic multileaf collimators (DMLC), to optimize dose conformality, delivery efficiency, accuracy and reliability. We developed RapidArc system commissioning and quality assurance (QA) procedures. Methods and Materials: Tests have been designed that evaluate RapidArc performance in a stepwise manner. First, the accuracy of DMLC position during gantry rotation is examined. Second, the ability to vary and control the dose-rate and gantry speed is evaluated. Third, the combined use of variable DMLC speed and dose-rate is studied. Results: Adapting the picket fence test for RapidArc, we compared the patterns obtained with stationary gantry and in RapidArc mode, and showed that the effect of gantry rotation on leaf accuracy was minimal ({<=}0.2 mm). We then combine different dose-rates (111-600 MU/min), gantry speeds (5.5-4.3{sup o}/s), and gantry range ({delta}{theta} = 90-12.9 deg.) to give the same dose to seven parts of a film. When normalized to a corresponding open field (to account for flatness and asymmetry), the dose of the seven portions show good agreement, with a mean deviation of 0.7%. In assessing DMLC speed (0.46, 0.92, 1.84, and 2.76 cm/s) during RapidArc, the analysis of designed radiation pattern indicates good agreement, with a mean deviation of 0.4%. Conclusions: The results of these tests provide strong evidence that DMLC movement, variable dose-rates and gantry speeds can be precisely controlled during RapidArc.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas

Purpose: Volumetric modulated arc therapy (VMAT), the predecessor to Varian's RapidArc, is a novel extension of intensity-modulated radiotherapy (IMRT) wherein the dose is delivered in a single gantry rotation while the multileaf collimator leaves are in motion. Leaf positions and the weights of field samples along the arc are directly optimized, and a variable dose rate is used. This planning study compared seven-field coplanar IMRT (cIMRT) with VMAT for high-grade gliomas that had planning target volumes (PTVs) overlapping organs at risk (OARs). Methods and Materials: 10 previously treated patients were replanned to 60 Gy in 30 fractions with cIMRT and VMAT using the following planning objectives: 98% of PTV covered by 95% isodose without violating OAR and hotspot dose constraints. Mean OAR doses were maximally decreased without reducing PTV coverage or violating hotspot constraints. We compared dose-volume histogram data, monitor units, and treatment times. Results: There was equivalent PTV coverage, homogeneity, and conformality. VMAT significantly reduced maximum and mean retinal, lens, and contralateral optic nerve doses compared with IMRT (p < 0.05). Brainstem, chiasm, and ipsilateral optic nerve doses were similar. For 2-Gy fractions, mean monitor units were as follows: cIMRT = 789 +- 112 and VMAT = 363 +- 45 (relative reduction 54%, p = 0.002), and mean treatment times (min) were as follows: cIMRT = 5.1 +- 0.4 and VMAT = 1.8 +- 0.1 (relative reduction 65%, p = 0.002). Conclusions: Compared with cIMRT, VMAT achieved equal or better PTV coverage and OAR sparing while using fewer monitor units and less time to treat high-grade gliomas.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Out-of-Field Cell Survival Following Exposure to Intensity-Modulated Radiation Fields

Purpose: To determine the in-field and out-of-field cell survival of cells irradiated with either primary field or scattered radiation in the presence and absence of intercellular communication. Methods and Materials: Cell survival was determined by clonogenic assay in human prostate cancer (DU145) and primary fibroblast (AGO1552) cells following exposure to different field configurations delivered using a 6-MV photon beam produced with a Varian linear accelerator. Results: Nonuniform dose distributions were delivered using a multileaf collimator (MLC) in which half of the cell population was shielded. Clonogenic survival in the shielded region was significantly lower than that predicted from the linear quadratic model. In both cell lines, the out-of-field responses appeared to saturate at 40%-50% survival at a scattered dose of 0.70 Gy in DU-145 cells and 0.24 Gy in AGO1522 cells. There was an approximately eightfold difference in the initial slopes of the out-of-field response compared with the {alpha}-component of the uniform field response. In contrast, cells in the exposed part of the field showed increased survival. These observations were abrogated by direct physical inhibition of cellular communication and by the addition of the inducible nitric oxide synthase inhibitor aminoguanidine known to inhibit intercellular bystander effects. Additional studies showed the proportion of cells irradiated and dose delivered to the shielded and exposed regions of the field to impact on response. Conclusions: These data demonstrate out-of-field effects as important determinants of cell survival following exposure to modulated irradiation fields with cellular communication between differentially irradiated cell populations playing an important role. Validation of these observations in additional cell models may facilitate the refinement of existing radiobiological models and the observations considered important determinants of cell survival.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Single Fraction Versus Fractionated Linac-Based Stereotactic Radiotherapy for Vestibular Schwannoma: A Single-Institution Experience

Purpose: To evaluate and compare outcomes for patients with vestibular schwannoma (VS) treated in a single institution with linac-based stereotactic radiosurgery (SRS) or by fractionated stereotactic radiotherapy (SRT). Methods and Materials: One hundred and nineteen patients (SRS = 78, SRT = 41) were treated. For both SRS and SRT, beam shaping is performed by a mini-multileaf collimator. For SRS, a median single dose of 12.5 Gy (range, 11-14 Gy), prescribed to the 80% isodose line encompassing the target, was applied. Of the 42 SRT treatments, 32 treatments consisted of 10 fractions of 3-4 Gy, and 10 patients received 25 sessions of 2 Gy, prescribed to the 100% with the 95% isodose line encompassing the planning target volume. Mean largest tumor diameter was 16.6 mm in the SRS and 24.6 mm in the SRT group. Local tumor control, cranial nerve toxicity, and preservation of useful hearing were recorded. Any new treatment-induced cranial nerve neuropathy was scored as a complication. Results: Median follow-up was 62 months (range, 6-136 months), 5 patients progressed, resulting in an overall 5-year local tumor control of 95%. The overall 5-year facial nerve preservation probability was 88% and facial nerve neuropathy was statistically significantly higher after SRS, after prior surgery, for larger tumors, and in Koos Grade {>=}3. The overall 5-year trigeminal nerve preservation probability was 96%, not significantly influenced by any of the risk factors. The overall 4-year probability of preservation of useful hearing (Gardner-Robertson score 1 or 2) was 68%, not significantly different between SRS or SRT (59% vs. 82%, p = 0.089, log rank). Conclusion: Linac-based RT results in good local control and acceptable clinical outcome in small to medium-sized vestibular schwannomas (VSs). Radiosurgery for large VSs (Koos Grade {>=}3) remains a challenge because of increased facial nerve neuropathy.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Automatic Prostate Tracking and Motion Assessment in Volumetric Modulated Arc Therapy With an Electronic Portal Imaging Device

Purpose: To assess the prostate intrafraction motion in volumetric modulated arc therapy treatments using cine megavoltage (MV) images acquired with an electronic portal imaging device (EPID). Methods and Materials: Ten prostate cancer patients were treated with volumetric modulated arc therapy using a Varian TrueBeam linear accelerator equipped with an EPID for acquiring cine MV images during treatment. Cine MV images acquisition was scheduled for single or multiple treatment fractions (between 1 and 8). A novel automatic fiducial detection algorithm that can handle irregular multileaf collimator apertures, field edges, fast leaf and gantry movement, and MV image noise and artifacts in patient anatomy was used. All sets of images (approximately 25,000 images in total) were analyzed to measure the positioning accuracy of implanted fiducial markers and assess the prostate movement. Results: Prostate motion can vary greatly in magnitude among different patients. Different motion patterns were identified, showing its unpredictability. The mean displacement and standard deviation of the intrafraction motion was generally less than 2.0 ± 2.0 mm in each of the spatial directions. In certain patients, however, the percentage of the treatment time in which the prostate is displaced more than 5 mm from its planned position in at least 1 spatial direction was 10% or more. The maximum prostate displacement observed was 13.3 mm. Conclusion: Prostate tracking and motion assessment was performed with MV imaging and an EPID. The amount of prostate motion observed suggests that patients will benefit from its real-time monitoring. Megavoltage imaging can provide the basis for real-time prostate tracking using conventional linear accelerators.

62 RADIOLOGY AND NUCLEAR MEDICINE↗